Introduction
Antibodies are being used increasingly as reagents in biochemical and biological studies of glycoproteins, for example, in the search for glycoproteins with important roles in embryonic development, cell differentiation and oncogenesis, and as a means of monitoring the biosynthesis and subcellular location of specific glycoproteins such as enzymes and receptors. Crucial for the proper application of antibodies in such experiments is knowledge of the determinants they recognize. A glycoprotein may contain many antigenic determinants, each consisting of up to seven monosaccharides or amino acids in consecutive sequence (Kabat, 1976) or, in the case of polypeptides, in non-continuous sequence brought together by chain folding (Lerner, 1984; Walter, 1986) . Unravelling the specificities contained in conventional (polyclonal) antisera raised against glycoproteins often presents problems due to the mixture of antibodies present with different combining specificities. It is often difficult to distinguish specificities directed against peptide determinants from those directed against carbohydrate structures on a glycoprotein. Monoclonal antibodies have the advantage in this respect since each is a single antibody population with a narrow specificity.
As a result of work with naturally-occurring monoclonal autoantibodies and the widespread use of hybridomaderived antibodies, there has been an increased awareness of carbohydrates as antigenic determinants of glycoproteins, since it has become apparent that many differentiation antigens ofnormal and neoplastic cells are oligosaccharide determinants of glycoproteins and glycolipids rather than peptide determinants (Feizi, 1985 (Feizi, , 1987 Hakomori, 1985) . Thus, carbohydrate antigens which were previously the interest of specialist immunochemists are now of wide relevance to both biochemists and cell biologists.
We do not intend here to make an exhaustive review of antigens found to date on glycoprotein oligosaccharides; rather we shall discuss some examples of whole cells (haematopoietic and embryonic) and specific glycoproteins (a receptor and a glycosyltransferase) where carbohydrate structures have been found to be major antigenic determinants. We shall also discuss approaches to the study of antigenicity (reactivity with antibodies) and immunogenicity (ability to elicit antibodies) of the oligosaccharides of glycoproteins and the opportunities now available for exploiting antibodies with defined carbohydrate specificities as probes of the structure, tissue distribution and function of glycoprotein oligosaccharides. We also include in this article a hypothesis which considers the biological relevance and possible inter-relationships of three areas of knowledge: (a) the occurrence of the same carbohydrate antigens/structures on diverse and unrelated glycoproteins, (b) marked Vol. 245 changes in glycoprotein oligosaccharide antigens/structures during embryonic development, differentiation and oncogenesis and (c) the occurrence of an array of carbohydrate-binding proteins (lectins) in mammalian cells.
Glycoprotein oligosaccharides as major antigens of whole cells
Antibodies have been used extensively to monitor changes in antigenicity at the cell surface during embryogenesis and cellular differentiation. Two cell types which have been studied extensively are cultured teratocarcinoma cell lines which can be chemically induced to undergo changes that mimic early embryonic events, and a promyelocytic cell line HL60 which can be induced to differentiate along either the granulocytic or monocytic pathways.
Work with syngeneic polyclonal antisera to the mouse teratocarcinoma cell line, F9, showed that early embryonic cells express an antigen, termed F9 antigen (Jacob, 1979) . The structures of the F9 antigenic determinant(s) were not established; however, it was shown that undifferentiated teratocarcinoma cells and embryonic cells are rich in glycoproteins with long carbohydrate chains of poly-N-acetyl-lactosamine type which react with antibodies to F9 antigen (Muramatsu et al., 1979) . Work with monoclonal antibodies has shown that several carbohydrate antigens which change dramatically at successive stages of differentiation are borne on poly-N-acetyl-lactosamine chains of polydisperse, high-Mr glycoproteins .
Among these antigens are the I antigenic determinants associated with branched poly-N-acetyl-lactosamine structures (Feizi et al., 1971; Watanabe et al., 1979) which are expressed throughout the pre-implantation stage , SSEA-1 antigen associated with al-3 fucosylated N-acetyl-lactosamine which first appears at the 8-cell stage of the mouse embryo when compaction takes place (Solter & Knowles, 1978) and the i antigen associated with unbranched poly-N-acetyl-lactosamine structures (Niemann et al., 1978) which first appears at the onset of differentiation ofthe primary endoderm , as shown in Fig. 1 . These antigens diminish or disappear at later stages of development and become restricted to only certain cell types in adult tissues.
An important aspect of changes in expression of these oligosaccharide antigens is the masking effect of additional glycosylations (Feizi, 1981a,b) or other modifications such as sulphation Tang et al., 1986 (Feizi, 1981b) . This is important to bear in mind since the appearance of new antigens at the cell surface may not be synonymous with the biosynthesis of new membrane proteins, and loss of antigenicity may not mean lack of biosynthesis of the relevant oligosaccharides.
There are a number of analogies between the embryo/teratocarcinoma cells (Martin, 1980) and promyelocytic cells (Gahmberg et al., 1979) . A high proportion of monoclonal antibodies to the promyelocytic leukaemia cell line, HL60, recognize an antigen related to SSEA-1 (reviewed by Feizi, 1984, and Magnani, 1984) . Here, also, diffusely migrating cell surface glycoproteins of high Mr (greater than 100000) are major carriers of this antigen detected both by immunoblotting of total cell lysates and immunoprecipitation of radiolabelled cell surface glycoproteins (Feizi, 1983; Urdal et al., 1983; Tetteroo et al., 1984; . In addition, the i antigenic determinant, associated with linear poly-N-acetyl-lactosamine structures (i Den) is borne on these glycoproteins Fig. 2 ). There is a lack of reactivity with anti-I Step (Fig. 2 ) which recognizes long, branched poly-N-acetyl-lactosamine structures (cf. Fig. 1 ). With anti-I Ma, which recognizes the short branch-point N-acetyl-lactosamine sequence, there is a strong reactivity with a different set of glycoproteins of average Mr 170000. Thus, two major glycoprotein families are discerned on the surface of HL60 cells with respect to their sugar chain immunoreactivities, the first having linear poly-N-acetyl-lactosamine backbones and corresponding in structure to the N-glycosidically linked oligosaccharides (Mizoguchi et al., 1984; Spooncer et al., 1984) and the second having short, branched backbones of the type occurring among the O-glycosidically linked oligosaccharides of the major sialoglycoprotein termed leukosialin (Carlsson et al., 1986) .
Among the peripheral blood cells of man, the SSEA-1 determinant is almost exclusively expressed on granulocytes (reviewed by Feizi, 1984, and Magnani, 1984) . HL60 cells that have been induced to differentiate along the granulocyte pathway also express SSEA-1 (Tetteroo et al., 1984 (Gahmberg & Hakomori, 1973 ) the cells were lysed with the zwitterionic detergent Empigen, immune precipitates were obtained and subjected to SDS/polyacrylamide gel electrophoresis and autoradiography as described previously smaller amounts than in promyelocytic (HL60) cells (Spooncer et al., 1984; Mizoguchi et al., 1984) .
On monocytes, the SSEA-1 and i antigens cannot be detected, but are revealed after treatment of the cells with neuraminidase . Reduced expression of SSEA-1 was also noted on HL60 cells which were induced to differentiate into monocytes, and the antigen could be revealed by neuraminidase treatment (Tetteroo et al., 1984) . This antigen is also revealed on acute lymphoblastic leukaemia cells after neuraminidase treatment Knapp et al., 1984) . Thus, antibodies to 3-fucosyl-N-acetyl-lactosamine have been useful as reagents in studies of the glycosylation changes during differentiation not only in mouse embryonic cells but also in human leucocytes.
There are species differences in the expression of several carbohydrate antigens. For example, human but not mouse granulocytes express SSEA-1 antigen (Knowles et al., 1982; . Moreover, the SSEA-1 determinant is restricted to very few tissues in the adult mouse (Fox et al., 1983 ) but this structure is widely distributed in human tissues and secreted glycoproteins (reviewed by Gooi et al., 1981) . In addition, there are cell-type differences in the relative proportions of glycoproteins and glycolipids that carry this antigen. For example, the SSEA-1, I and i antigens are expressed predominantly on glycoproteins of embryonal carcinoma cells , but in myeloid cells they are expressed both on glycoproteins and glycolipids (Urdal et al., 1983; Uemura et al., 1985) . Information so far available suggests that the Y antigen (2',3-difucosyl-N-acetyl-lactosamine) is predominantly expressed on glycolipids of myeloid cells since it was readily detected by immunostaining of glycolipids derived from granulocytes (Uemura et al., 1985) , but was barely detectable on glycoproteins of HL 60 cells by immunoblotting of total cell lysates (R. A. Childs, unpublished work).
These are just two differentiation systems in which glycoprotein oligosaccharides feature as major antigenic determinants of whole cells. They may be added to a growing list of carbohydrate antigens on cell surfaces headed by the ABO, Lewis and P blood group antigens of erythrocyte membranes (Watkins, 1980; Kabat, 1982) and the glycoprotein antigens of the normal and neoplastic epithelia of the gastrointestinal tract A43 1 cells are especially rich in receptors for epidermal growth factor. Numerous hybridoma antibodies have been raised to this receptor glycoprotein by immunizing mice with the cell membranes or the isolated receptor. As part of a programme of studies of carbohydrate antigens on biologically active glycoproteins, we have looked for carbohydrate specificities among some 20 hybridoma antibodies to the receptor glycoprotein raised in different laboratories and found evidence for blood-group-related carbohydrate specificities in no less than 15 (Gooi et al., 1983b (Gooi et al., , 1985a . The immunogenicity of the carbohydrate moiety of this receptor glycoprotein is endorsed by the work of others (Parker et al., 1984; Le Pendu et al., 1985) .
These observations prompted direct analyses of the carbohydrate antigens on the purified EGF receptor glycoprotein, using, in addition to the 'anti-receptor' antibodies, a panel of monoclonal antibodies directed at various members of the blood group family of oligosaccharide antigens . In Fig. 3 are shown the structures of antigens detected on the backbone and peripheral domains of the carbohydrate chains of the receptor glycoprotein. These include several Type 1 (Gal/?1-3GlcNAc) and Type 2 (Gal/Jl4GlcNAc) based structures such as branched SSEA-1 and 2',3-difucosyl-N-acetyl-lactosamine (Y antigen structure) on poly-N-acetyl-lactosamine backbones, variants of blood group A antigen, and blood group Lewisa also on poly-N-acetyl-lactosamine backbones. These structures are apparently on oligosaccharides that are N-glycosidically linked to the receptor protein, since no evidence has been obtained for the presence of 0-linked structures on the epidermal growth factor receptor from this cell line Childs et al., 1984; Cummings et al., 1985) .
Monoclonal antibodies have also been used in immunoblotting experiments (Childs et al., 1986) to investigate the carbohydrate antigens of the glycoprotein enzyme, galactosyltransferase, purified in soluble form from human milk. The structures deduced to be present on the enzyme isolated from a presumed group A secretor and a group 0 non-secretor are summarized in Fig. 4 . More recent studies using oligosaccharides released from galactosyltransferase indicate that the Lea and SSEA-1 antigens occur both on 0-and Nglycosidically linked chains of the enzyme glycoprotein (Tang & Feizi, 1987) . These observations, in turn, prompted a study of blood-group-related carbohydrate specificities among rabbit antisera and affinity-purified antibodies to galactosyltransferase, and revealed that various antibody preparations contain anti-blood group A, anti-blood group HLeb or anti-Lea and anti-SSEA-1 related specificities as minor but non-trivial populations (Childs et al., 1986) (Childs et al., 1986) hydrate specificities are a feature, not only among hybridoma antibodies but also among conventional antisera raised against glycoproteins. When such antisera are used for immunohistochemical studies, different glycoproteins known to express blood group antigens, e.g. mucins and intestinal hydrolases (Triadou, 1984) (Childs et al., 1986) due to the availability of glycoproteins and tissues from individuals of known blood group and secretor status. However, as discussed in the following section, the conclusive demonstration of other types ofcarbohydrate specificities can be difficult, but their importance should not be underestimated. The generality of this problem is reinforced by evidence that rabbit antibodies to two other enzyme glycoproteins, the acid hydrolases of Dictyostelium discoideum (Freeze et al., 1984) and to a fungal glucosyltransferase (Pazur et al., 1986) protein (Donald et al., 1984) , the pentasaccharide structure: GalNAcf1-4Gal,1-3GalNAc J 2,3 2,6
NeuAca NeuAca among the 0-linked chains of glycophorin A from Cad antigen-positive erythrocytes (Blanchard et al., 1983) , and the identification of chondroitin sulphate-related sequences as antigens of nerve adhesion molecules (Chou et al., 1985; Kruse et al., 1985) and as target antigens of autoantibodies associated with polyneuropathy (Kabat et al., 1984 (Hanisch et al., 1985) . Although all glycoprotein oligosaccharide sequences are potential antigens, the antigenic determinants characterized thus far largely involve the backbone and peripheral domains common to 0-and N-linked chains and the core regions of O-linked chains (Rahman & Longenecker, 1982; Steuden et al., 1985; Hirohashi et al., 1985) . Since neoglycolipid constructs are of proven immunogenicity (Lai & Kabat, 1985) , it should be possible to raise monoclonal antibodies to desired neoglycolipid constructs (Tang & Feizi, 1987) or other oligosaccharide structures, such as various coreregion variants of N-linked oligosaccharides (Kobata, 1984) and the distinctive oligosaccharide structures that occur on lysosomal enzymes (Kornfeld & Kornfeld, 1985) , pituitary hormones (Baenziger, 1985) and tumour derived glycoproteins (Kobata & Yamashita, 1984; Yamamoto et al., 1985) . Such antibodies would be invaluable for mapping the distribution of specific structures on purified glycoproteins and within cells. (Carding et al., 1984) . Traditionally, susceptibility to mild periodate treatment is considered indicative of the carbohydrate nature of antigens. A mild periodate oxidation procedure was standardized recently for destroying monosaccharides at the non-reducing termini of antigenically-active carbohydrate chains (Woodward et al., 1985) . Using this procedure, the fucose-dependent Lea antigen was destroyed without altering the protein epitopes on bovine serum albumin. As discussed in that report, carbohydrate determinants located on nonterminal domains of carbohydrate chains are unaffected by this procedure. We have observed that under the conditions used by Woodward et al. (1985) the linear poly-N-acetyl-lactosamine determinant recognised by an anti-i antibody (Tho) and the branched poly-N-acetyllactosamine determinant recognised by anti-I (Step) that are expressed on meconium glycoproteins and sheep gastric mucins, respectively, are not destroyed, whereas SSEA-1, i (Den), on meconium, and I (Ma), on sheep gastric mucins, are destroyed (P. W. Tang & T. Feizi, unpublished work) . Both the anti-i Tho and anti-I Step (Gardas, 1982; Uemura et al., 1983) can react with internal domains of poly-N-acetyllactosamine chains and do not require terminal galactose residues to be present. In contrast, anti-SSEA-1 has a strict requirement for a l-3-linked terminal fucose Hounsell et al., 1981) and anti-I Ma and anti-i Den require terminal galactose residues (Feizi et al., 1971; Tang et al., 1986) . Moreover, there remains a question mark as to whether peptide determinants are always resistant to mild periodate treatment, since the Rh(D) antigen of erythrocytes, now thought to be of ipolypeptide nature (Moore et al., 1982) , was susceptible to the mildest periodate oxidation conditions (Moskowitz & Treffers, 1950; Morgan & Watkins, 1951) .
Other ways of carbohydrate elimination, e.g. treatments of whole cells or glycoproteins with exo-or endo-glycosidases or biosynthesis in the presence of N-glycosylation inhibitors, e.g. tunicamycin (Struck & Lennarz, 1980) , may be used, but a lack of effect may mean that the wrong, enzymes have been used or that the oligosaccharides are 0-rather than N-glycosidically linked. A loss or reduction of antigenicity after chemical deglycosylation (Mort & Lamport, 1977) would favour a carbohydrate specificity, providing the peptide moiety is unaffected, but complete deglycosylation by chemical means may be difficult to achieve (Tang & Feizi, 1987) .
From all of the aforesaid, it is clear that there is a need for procedures that enable direct antigenic analyses of glycoprotein-derived oligosaccharides. With this in mind, a micro-immunoassay procedure was designed recently (Tang et al., 1985; Tang & Feizi, 1987) (Muramatsu et al., 1978; Childs et al., 1983; Pennington et al., 1985) . To the left are shown unsubstituted poly-N-acetyl-lactosamine backbones, with short branches reactive with anti-I Ma (Feizi et al., 1971 ) and M18 (Gooi et al., 1983c) antibodies (Ma+, M 18+); long branched sequences reactive with anti-I Step (Step+) and unbranched sequences reactive with anti-i Den (Den+). As shown on the right, these determinants are masked (Den-, Ma-, M 18-) in the presence of terminal sialic acid residues but are revealed by sialidase (S+); the M 18 determinant is masked by terminal a-galactosyl residues and is revealed by a-galactosidase (G+). Also shown are the a-galactosyl termini reactive with an anti-blood group B antibody (B+), designated NB10/8B4 (Voak et al., 1983 and the mono-and di-fucosyl structures reactive with anti-SSEA-1 and C14 antibodies (Brown et al., 1983) respectively. Internal fl-galactosyl linkages on linear poly-N-acetyl-lactosamine domains that are susceptible to digestion with endo-fl-galactosidase (Fukuda et al., 1979) are indicated by the short black arrows. Internal fl-galactosyl linkages at branch-points, which are resistant to endo-/J-galactosidase are indicated by the white arrows. The inset depicts the I(Ma), M18, SSEA-l and C14 antigenic determinants, carried on an N-glycosidically linked glycoprotein oligosaccharide with short backbone sequences, which are resistant to digestion with endo-,1-galactosidase. Pennington, 1985) .
should be adaptable not only for initial screening to determine whether antibodies are directed at carbohydrate antigens on glycoproteins, but also for eventually identifying the antigenic oligosaccharides among heterogeneous mixtures released from glycoproteins.
Apart from their roles as 'free-standing' antigenic determinants on glycoproteins, oligosaccharides have marked effects on the antigenicities of peptide moieties, for example with the blood group M and N antigens on human sialoglycoproteins (Lisowska, 1981; Wasniowska et al., 1985) and certain viral glycoprotein antigens (Alexander & Elder, 1984) . It has been suggested that the immunogenicities of peptide moieties of certain viral envelope glycoproteins may also be influenced by their oligosaccharides (Elder et al., 1986 ).
Antibodies as probes of structure, tissue distribution and function of oligosaccharides Elucidation of the structures of oligosaccharide antigens involves processes that are labour-intensive by comparison with protein and nucleic acid sequencing techniques which are now largely automated. Moreover, conclusive structural assignments for novel antigenic sequences requires rigorously purified oligosaccharides for analysis by g.l.c.-m.s. and n.m.r. as well as antigenic analyses (Hounsell, 1987) . But the reward that follows from using such defined oligosaccharides to characterize the binding specificity of antibodies is the availability of sequence-specific antibodies which have tremendous potential as probes of oligosaccharide structure. We 1987 predict that micro-immunosequencing procedures using well-characterized monoclonal antibodies in conjunction with lectins (Finne et al., 1980; Cummings & Kornfeld, 1982) and exo-and endo-glycosidases Scudder et al., 1986; Tang et al., 1986) may before long become the order of the day, particularly with glycoprotein oligosaccharides of the poly-N-acetyllactosamine series which are usually so heterogeneous and hard to purify that sequence information can at best be given as averages (Mizugochi et al., 1984; Spooncer et al., 1984) . Fig. 5 shows a hypothetical carbohydrate chain with poly-N-acetyl-lactosamine backbone sequences characteristic of mouse embryonic cells. Various antigenic determinants recognized by monoclonal antibodies and the predicted cleavage sites Usifg endo-fl-galactosidase, and the changes in antigenicity after treatment with sialidase or z-galactosidase, are indicated.
Immunohistochemistry with monoclonal antibodies specific for structural variants among heterogeneous glycoprotein oligosaccharides holds promise for visualizing the distribution and topography of the individual structures Mollicone et al., 1985) , and should serve as a guide for the design of appropriate experiments to test the functions of each structure. For example, it was following on from the immunohistochemical experiments described above which revealed the distribution of the I, i and SSEA-1 antigens on the mouse embryo that meaningful investigations were performed of the involvement of poly-Nacetyl-lactosamine sequences and their a1-3 fucosylated derivatives in the adhesion (compaction) of embryonic cells. The results have implicated carbohydrate sequences of the poly-N-acetyl-lactosamine series in this first cell-to-cell interaction event in the embryo (Bird & Kimber, 1984; Fenderson et al., 1984; Rastan et al., 1985) .
From observations made thus far with these antibodies to the blood group family of oligosaccharide structures, it is clear that a diverse array of macromolecules are decorated with these structures. These include mucins, intestinal hydrolases, galactosyltransferase and the receptor for epidermal growth factor to name but a few, as well as glycosphingolipids. The observation that only selected carbohydrate antigens among those on A431 cells are represented on the receptor for epidermal growth factor suggests that glycoproteins in a given cell may be divided into subsets based on their content of oligosaccharide antigens/structures. We have speculated previously that oligosaccharide structures shared between the epidermal growth factor receptor, other glycoproteins and glycolipids may be the basis of interactions mediated by specific carbohydratebinding proteins (endogenous lectins) through which the receptor glycoprotein might be linked to other extra-and intra-cellular signalling systems (Feizi & Childs, 1985) . These thoughts were stimulated by reports that two of the hybridoma antibodies to the epidermal growth factor receptor, TL5 and 29.1, which were found to have blood group A-related specificities (Gooi et al., 1983b (Gooi et al., , 1985a can behave as growth factor agonists: antibody TL5 was reported to stimulate DNA synthesis in fibroblasts when bound to these cells and cross-linked by anti-mouse antibodies (Schreiber et at., 1983) . Both antibodies TL5 and 29.1 were reported to enhance self-phosphorylation of the partially purified epidermal growth factor receptor Vol. 245 and to increase the affinity of the receptor for the growth factor (Yarden & Schlessinger, 1985) . Taken together, these observations may be important clues to the functions of the blood group antigens. It would be an exciting development if endogenous lectins complementary to the blood group isoantigens could be demonstrated in individuals of different blood groups. There is already evidence for reactivities with blood-group oligosaccharides among a family of soluble mammalian lectins (S. R. Carding, R. A. Childs & T. Feizi, cited by Scudder et al., 1982; Leffler & Barondes, 1986) .
Other observations that are consistent with the involvement of carbohydrate-recognizing proteins in growth regulation or cell activation include the modulation of the activities of growth factor receptors (Bremer et al., 1984 (Bremer et al., , 1986 ) and of protein kinase C (Kim et al., 1986; Fujiki et al., 1986) by specific glycolipids, the lack of signal transduction by glycoprotein hormones after they have been deglycosylated (Bahl & Kalyan, 1983; Sairam & Bhargavi, 1985) , and the inhibition of signal transduction by glycopeptides and oligosaccharides (Calvo & Ryan, 1985) .
Our original hypothesis (Feizi & Childs, 1985) can now be extended and one can envisage a network (Fig. 6 ) based on glycoconjugates (glycoproteins, proteoglycans and glycolipids) linked through specific lectins which serve as an adjustable connecting system between various response pathways and hence tune the cells response to various stimuli. For example, through such interactions, down-or up-regulation and recycling of various receptor systems may be co-ordinated. Control of the network would be two-fold: activity of the appropriate lectins and expression of the correct carbohydrate chains. Among thei lectins in this scheme we include (Feizi, 1985) the carbohydrate-binding proteins of infective agents. The lectin activities may be regulated not only by the absolute amounts of the proteins, but by short range factors such as cation levels (Goldstein & Hayes, 1978; Barondes, 1984; Lis & Sharon, 1986) . Changes have been observed in activities of lectins, or levels of proteins antigenically related to lectins, during embryonic development (Barondes, 1984) and in stimulated and transformed cells (Carding et al., 1985; Raz & Lotan, 1986; Gabius et al., 1986) . A most striking example of uncoupling of functional lectinoligosaccharide complexes as a result of structural defects in glycoprotein oligosaccharides is I cell disease, where there is a failure of correct routing (by mannose 6-phosphate binding proteins) of newly synthesized acid hydrolases to lysosomes due to a lack of phosphorylation of mannose residues of these enzyme glycoproteins (Sly & Fisher, 1982; Kornfeld & Kornfeld, 1985) . Apart from mediation of intracellular events by interaction of lectins with glycoprotein oligosaccharide variants, other possible effects of variable glycosylation include impairment of fibroblast adhesion (Edwards et al., 1976; Stojanovic et al., 1983) and changes in metastatic potential of tumour cells (Finne, 1983) . Moreover, glycosyltransferase activities (and by inference glycoprotein oligosaccharide structures) may be modulated by endogenous lectins (Scudder et al., 1982 biology. We have highlighted examples of single carbohydrate antigens on plasma membrane glycoproteins which behave as distinctive markers of differentiation stages. We have seen how antigenic cross-reactions between different glycoproteins may be mediated by shared oligosaccharide sequences. We now raise the possibility that interactions in vivo between different receptor systems may be mediated by shared carbohydrate structures and an array of endogenous lectins.
We have cited only a few examples among numerous antibodies that were originally raised to glycoprotein receptors, glycoprotein enzymes or to differentiation antigens of whole cells, and later found to recognize oligosaccharide determinants. We predict that immunosequencing procedures exploiting these extraordinary byproducts of the hybridoma approach (K6hler & Milstein, 1975) , as well as intentionally raised antibodies to glycoprotein oligosaccharides, will be used widely both for structural studies of glycoprotein oligosaccharides and for visualizing their subcellular organization. A new micro-immunochemical approach involving the construction of lipid conjugates of 0-and N-linked glycoprotein oligosaccharides prior to antigenic analyses should greatly facilitate the identification of novel carbohydrate antigens on glycoproteins. The availability of monoclonal antibodies with well defined carbohydrate specificities is now of key importance to the biochemistry of glycoproteins.
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